Emcure Pharmaceuticals IPO is to open on July 3. Emcure Pharmaceuticals is a Mainline IPO to raise ₹1952.03 crores via IPO. The Emcure Pharmaceuticals IPO price band is fixed at ₹960 to ₹1008 with a market lot of 14 Shares. EEmcure Pharmaceuticals is an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. They are a research and development (R&D) driven company with a differentiated product portfolio that includes orals, injectables, and biotherapeutics, which has enabled them to reach a range of target markets across over 70 countries, with a strong 218 presence in India, Europe, and Canada.
What is Emcure Pharmaceuticals IPO GMP Today?
The Emcure Pharmaceuticals IPO GMP aka Grey Market Premium is ₹300.
What is Emcure Pharmaceuticals IPO Kostak Rates Today?
The Emcure Pharmaceuticals IPO Kostak Rate is ₹-.
What is Emcure Pharmaceuticals IPO Subject to Sauda Price Today?
The Emcure Pharmaceuticals IPO subject to sauda rates is ₹2500.
Emcure Pharmaceuticals IPO Expected Returns?
The Emcure Pharmaceuticals expected return is 30%.
Emcure Pharmaceuticals IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | Kostak | Subject to |
| Today | ₹300 | ₹- | ₹2500 |
| 27 June | ₹- | ₹- | ₹- |
Emcure Pharmaceuticals IPO GMP aka Grey Market Premium FAQs:
What is Emcure Pharmaceuticals IPO GMP Today?
Emcure Pharmaceuticals IPO GMP is ₹300 as of today.
What is Emcure Pharmaceuticals IPO Kostak Rate Today?
Emcure Pharmaceuticals IPO Kostak Rate is ₹- as of today.
What is Emcure Pharmaceuticals IPO Subject to Sauda Today?
Emcure Pharmaceuticals IPO Subject to Sauda is ₹2500 as of today.
What is Emcure Pharmaceuticals IPO Expected Returns?
Emcure Pharmaceuticals IPO Expected Returns is 30%.
Disclaimer:
- IPO Grey Market Premium (Emcure Pharmaceuticals IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
